Open AccessComplete eradication of chronic lymphocytic leukemia with unusual skin involvement of high mitotic index after time‐limited venetoclax/obinutuzumab treatment
Author(s) -
Dimou Maria,
Iliakis Theodoros,
Paradalis Vasileios,
Bitsani Aikaterini,
Kyrtsonis MarieChristine,
Panayiotidis Panayiotis
Publication year - 2021
Publication title -
clinical case reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.21
H-Index - 9
ISSN - 2050-0904
DOI - 10.1002/ccr3.4514
Subject(s) - venetoclax , obinutuzumab , medicine , chronic lymphocytic leukemia , leukemia , oncology , cancer research , immunology
The novel time‐limited combinations with the bcl‐2 inhibitor venetoclax can induce deep responses even in CLL cases with unusual and biologically aggressive presentations, like the skin masses of our patient.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom